Back to results
CompletedPhase 2

Estradiol Suppression for the Treatment of Metastatic Breast Cancer in Premenopausal Women

NCT00186121

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Stanford University School of Medicine

Stanford, California, United States

View on ClinicalTrials.gov
Estradiol Suppression for the Treatment of Metastatic Breast Cancer in Premenopausal Women — TrialFind